| cisplatin / Generic mfg. |
NCT01461057 / 2011-002331-25: A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer |
|
|
| Completed | 2a | 30 | Europe, RoW | Capecitabine, Xeloda, Cisplatin, Pertuzumab, Perjeta, Trastuzumab, Herceptin | Hoffmann-La Roche | Gastric Cancer | 03/15 | 10/17 | | |
|
NCT00002722: High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer |
|
|
| Completed | 2 | 135 | US | cisplatin, fluorouracil, leucovorin calcium | European Organisation for Research and Treatment of Cancer - EORTC | Gastric Cancer | 08/99 | | | |
NCT00002783: Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer |
|
|
| Completed | 2 | 50 | US | cisplatin, floxuridine, fluorouracil, leucovorin calcium, conventional surgery | Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI) | Gastric Cancer | 01/01 | 01/01 | | |
NCT00003055: Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer |
|
|
| Completed | 2 | | US | cisplatin, irinotecan hydrochloride | Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI) | Esophageal Cancer, Gastric Cancer | 04/01 | 04/01 | | |
NCT00006038: Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer |
|
|
| Completed | 2 | | US | cisplatin, docetaxel, floxuridine, fluorouracil, leucovorin calcium, conventional surgery | Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI) | Esophageal Cancer, Gastric Cancer | 02/03 | 02/03 | | |
NCT00042510: Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal Cancer |
|
|
| Completed | 2 | 103 | US | Treatment group | Cancer Advances Inc. | Stomach Neoplasms, Esophageal Neoplasms | 02/03 | 07/04 | | |
| Completed | 2 | | Europe | cisplatin, docetaxel, epirubicin hydrochloride, fluorouracil | Swiss Group for Clinical Cancer Research | Gastric Cancer | 07/03 | 07/03 | | |
NCT00003237: Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach |
|
|
| Completed | 2 | 55 | US, RoW | cisplatin, paclitaxel, surgical procedure | Eastern Cooperative Oncology Group, National Cancer Institute (NCI) | Esophageal Cancer, Gastric Cancer | 10/03 | | | |
NCT00165464: Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer |
|
|
| Completed | 2 | 54 | US | Taxotere, Cisplatin, Irinotecan | Dana-Farber Cancer Institute, Massachusetts General Hospital, Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Aventis Pharmaceuticals | Esophageal Cancer, Gastric Cancer, GE Junction Cancer | 03/05 | 04/09 | | |
NCT00190801: Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma |
|
|
| Completed | 2 | 50 | RoW | pemetrexed, cisplatin | Eli Lilly and Company | Gastrointestinal Neoplasms | | 09/05 | | |
NCT00011960: Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery |
|
|
| Completed | 2 | | US | cisplatin, paclitaxel, adjuvant therapy, radiation therapy | Radiation Therapy Oncology Group, National Cancer Institute (NCI) | Esophageal Cancer, Gastric Cancer | 05/06 | | | |
NCT00009880: Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach |
|
|
| Completed | 2 | | US | filgrastim, cisplatin, fluorouracil, paclitaxel, radiation therapy | Radiation Therapy Oncology Group, National Cancer Institute (NCI) | Esophageal Cancer, Gastric Cancer | 07/06 | | | |
NCT00005049: Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer |
|
|
| Completed | 2 | 45 | US | carboplatin, cisplatin, floxuridine | NYU Langone Health, National Cancer Institute (NCI) | Colorectal Cancer, Gastric Cancer, Gastrointestinal Carcinoid Tumor, Gastrointestinal Stromal Tumor, Ovarian Cancer, Peritoneal Cavity Cancer, Small Intestine Cancer | 11/06 | | | |
NCT00004103: Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer |
|
|
| Completed | 2 | | US | cisplatin, floxuridine, irinotecan hydrochloride, adjuvant therapy, conventional surgery, neoadjuvant therapy | NYU Langone Health, National Cancer Institute (NCI) | Gastric Cancer | 03/07 | 06/09 | | |
NCT00215995: Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas |
|
|
| Completed | 2 | 21 | US | Cisplatin, Platinol, Platinol-AQ, Irinotecan, Camptosar, ZD 1839, Iressa | H. Lee Moffitt Cancer Center and Research Institute, AstraZeneca | Esophageal Cancer, Gastric Cancer | 05/07 | 05/07 | | |
NCT00675194: Efficacy of Irinotecan and Capecitabine Versus(vs) Cisplatin and Capecitabine in Patients With Esophago-Gastric Cancer |
|
|
| Completed | 2 | 120 | Europe | Cisplatin, Irinotecan, Capecitabine | Johannes Gutenberg University Mainz | Gastric Cancer | | 10/07 | | |
NCT00084604: Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma |
|
|
| Completed | 2 | 47 | US | irinotecan hydrochloride, Campto, Camptosar, CPT-11, irinotecan, U-101440E, bevacizumab, anti-VEGF humanized monoclonal antibody, anti-VEGF monoclonal antibody, Avastin, rhuMAb VEGF, cisplatin, CACP, CDDP, CPDD, DDP, computed tomography, tomography, computed, laboratory biomarker analysis | National Cancer Institute (NCI) | Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach, Intestinal Adenocarcinoma of the Stomach, Mixed Adenocarcinoma of the Stomach, Recurrent Gastric Cancer, Stage IIIA Gastric Cancer, Stage IIIB Gastric Cancer, Stage IIIC Gastric Cancer, Stage IV Gastric Cancer | 10/07 | | | |
NCT00253370: Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction Cancer |
|
|
| Completed | 2 | 44 | US | BAY 43-9006, Sorafenib (NSC724772), BAY 54-9085 (tosylate salt), docetaxel, Taxotere, RP 56976, NSC #628503, cisplatin, Cis-diaminedichloroplatinum, Cis-diaminedichloroplatinum (II), diaminedichloroplatinum, cis-platinum, platinum, Platinol, Platinol-AQ, DDP, CDDP, DACP, NSC 119875. | National Cancer Institute (NCI) | Adenocarcinoma of the Gastroesophageal Junction, Metastatic Gastric Cancer, Advanced Unresectable Gastric Cancer | 05/08 | 09/10 | | |
NCT00568971: Study of Weekly DCF to Treat Advanced Gastric Cancer |
|
|
| Terminated | 2 | 40 | RoW | Docetaxel, Cisplatin, 5-Fu, wDCF | Fudan University | Gastric Cancer | 06/08 | 06/08 | | |
| Completed | 2 | 72 | Europe | Matuzumab, EMD 72000, Epirubicin, Cisplatin, Capecitabine | Merck KGaA, Darmstadt, Germany | Esophageal Cancer, Gastric Cancer | 07/08 | 08/08 | | |
NCT00394433: Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer |
|
|
| Completed | 2 | 38 | US | Bevacizumab, Avastin, Docetaxel, Taxotere, Docefrez, Cisplatin, Platinol-AQ, Platinol, Irinotecan, Camptosar | Dana-Farber Cancer Institute, Brigham and Women's Hospital, Massachusetts General Hospital, Genentech, Inc. | Esophageal Cancer, Stomach Cancer | 11/08 | 10/16 | | |
EXTRA, NCT00477711: A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric Cancer |
|
|
| Completed | 2 | 41 | RoW | cetuximab, cisplatin, capecitabine | Peking University, Merck Sharp & Dohme LLC | Gastric Cancer | 12/08 | 02/09 | | |
|
NCT01379482: Neo-adjuvant Chemo + Peritonectomy + Hyperthermic Intraperitoneal Chemo in Peritoneal Carcinomatosis From Gastric Cancer |
|
|
| Completed | 2 | 18 | Europe | Multimodal treatment, Irinotecan+Nordic FLv (6 pat.), EOX (6 pat.), FLOX (3 pat.), Docetaxel+Irinotecan+5-FU+LV (1 pat.), FOLFIRI (1 pat.), ECF (1 pat.), Cisplatin+doxorubicin (5 pat.)., Oxaliplatin +concomitant i.v. 5-FU+ i.v. LV (3 pat.), 5-FU + i.v. LV (5 pat.), Paclitaxel (1 pat.) | Uppsala University | Peritoneal Carcinomatosis, Gastric Cancer | 03/09 | 03/09 | | |
NCT00275951: Cetuximab Plus P-HDFL for the First-line Treatment of Advanced Gastric Cancer |
|
|
| Completed | 2 | 39 | RoW | Cetuximab Plus P-HDFL | National Taiwan University Hospital, Taipei Veterans General Hospital, Taiwan, National Health Research Institutes, Taiwan, Chang Gung Memorial Hospital, Tri-Service General Hospital | Gastric Cancer | 06/09 | 06/09 | | |
NCT00415168: Pemetrexed Plus Cisplatin as First-Line Treatment in Stage IV or Recurrence of Gastric Cancer |
|
|
| Completed | 2 | 53 | RoW | pemetrexed, LY231514, Alimta, cisplatin | Eli Lilly and Company | Gastric Cancer | 07/09 | 07/09 | | |
NCT00033657: Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer |
|
|
| Completed | 2 | 97 | US | cisplatin, cis-platinum, platinum, Platinol, Platinol-AQ, DDP, CDDP, DACP, NSC 119875, irinotecan hydrochloride, Camptothecin-11, CPT-11, Camptosar, paclitaxel, Taxol, NSC 125973, conventional surgery, radiation therapy | Eastern Cooperative Oncology Group, National Cancer Institute (NCI) | Esophageal Cancer, Gastric Cancer | 09/09 | 10/09 | | |
NCT00718913: Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric Cancer |
|
|
| Completed | 2 | 40 | Europe | Docetaxel, Taxotere, Cisplatin, CDDP, Capecitabine, Xeloda, Radiation, RT | Hellenic Oncology Research Group, University Hospital of Crete | Gastric Cancer | 09/09 | 09/09 | | |
NCT00743964: Phase II Study of Epirubicin, Cisplatin and Capecitabine (ECX) Versus Cisplatin and Capecitabine (CX) for Advanced Gastric Cancer (AGC) |
|
|
| Completed | 2 | 91 | RoW | Epirubicin, Cisplatin, capecitabine | Samsung Medical Center | Advanced Gastric Cancer | 10/09 | 10/09 | | |
NCT00003298: Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer |
|
|
| Completed | 2 | 39 | US | cisplatin, Platinol, cis-platinum, cisdiamminedichloroplatinum (II), Platinol-AQ, DACP, platinum, CDDP, DDP, fluorouracil, 5-Fluorouracil, 5-FU, Adrucil, Efudex, leucovorin calcium, Leucovorin, Wellcovorin, citrovorum factor, folinic acid, 5-formyl tetrahydrofolate, LV, LCV, paclitaxel, Taxol®, NSC 125973, surgery, radiation therapy | ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI) | Gastric Cancer | 02/10 | 05/11 | | |
NCT00006389: Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer |
|
|
| Completed | 2 | 12 | US | bryostatin 1, B705008K112, BRYO, Bryostatin, cisplatin, CACP, CDDP, CPDD, DDP, laboratory biomarker analysis | National Cancer Institute (NCI) | Stage III Gastric Cancer, Stage IV Gastric Cancer | 03/10 | 03/10 | | |
NCT00842491: Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer |
|
|
| Completed | 2 | 45 | RoW | endostar, cisplatin, capecitabine, capecitabine, cisplatin | Peking University, Xiansheng Pharmaceutical Company | Advanced Gastric Cancer | 04/10 | 12/10 | | |
NCT00454636 / 2006-004512-43: A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer. |
|
|
| Completed | 2 | 158 | Europe | Cisplatin, Capecitabine, Xeloda, Epirubicin, Oxaliplatin, Docetaxel | Hoffmann-La Roche | Gastric Cancer | 07/10 | 07/10 | | |
NCT00397904: Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin |
|
|
| Completed | 2 | 16 | US | cetuximab, cisplatin, irinotecan hydrochloride, immunohistochemistry staining method, laboratory biomarker analysis, biopsy | Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI) | Esophageal Cancer, Gastric Cancer | 09/10 | 09/10 | | |
NCT01824004: Postoperative Chemoradiotherapy With S-1 in Gastric Cancer |
|
|
| Completed | 2 | 46 | RoW | S-1, TS-1 | Chonnam National University Hospital | Gastric Cancer | 10/10 | 06/12 | | |
P-HDFL-DI, NCT00166881: Weekly Docetaxel/Irinotecan for Non-resectable Gastric Cancers After Cisplatin Plus 5-FU/Leucovorin |
|
|
| Completed | 2 | 29 | RoW | Docetaxel-Irinotecan, Docetaxel (taxotere), Irinotecan (campto, CPT-11) | National Taiwan University Hospital, Far Eastern Memorial Hospital | Gastric Cancer | 12/10 | 06/11 | | |
NCT00595972: Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer |
|
|
| Completed | 2 | 25 | RoW | ECF-endostar, treatment group | Fudan University | Gastric Cancer | 12/10 | 12/10 | | |
NCT00062374: Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction |
|
|
| Completed | 2 | 55 | US | Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Computed Tomography, CAT, CAT Scan, Computerized Axial Tomography, Computerized Tomography, CT, CT SCAN, tomography, Fludeoxyglucose F-18, 18FDG, FDG, fludeoxyglucose F 18, Fludeoxyglucose F18, Fluorine-18 2-Fluoro-2-deoxy-D-Glucose, Fluorodeoxyglucose F18, Fluorothymidine F-18, 18F-FLT, 3'-Deoxy-3'-(18F) Fluorothymidine, 3'-deoxy-3'-[18F]fluorothymidine, Fluorothymidine F 18, Irinotecan Hydrochloride, Campto, Camptosar, Camptothecin 11, Camptothecin-11, CPT 11, CPT-11, Irinomedac, U-101440E, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET SCAN, Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, Therapeutic Conventional Surgery | National Cancer Institute (NCI) | Gastric Adenocarcinoma, Stage II Gastric Cancer, Stage III Gastric Cancer, Stage IV Gastric Cancer | 06/11 | 06/11 | | |
NCT00848783: Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers |
|
|
| Terminated | 2 | 8 | US | Irinotecan, CPT-11, Cisplatin, Surgery, Floxuridine, FUDR, Capecitabine, Xeloda | NYU Langone Health | Gastric Cancer, Gastric Adenocarcinoma, Esophageal Cancer | 08/11 | 09/12 | | |
NCT00857246: Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer |
|
|
| Completed | 2 | 30 | US | Cetuximab, Erbitux, Irinotecan, CPT-11, Camptosar, Cisplatin, Platinol-AQ, Surgery, 5-FU, Fluorourocil, Radiation | NYU Langone Health, Bristol-Myers Squibb, Eli Lilly and Company | Gastric Cancer, Stomach Cancer | 09/11 | 10/15 | | |
| Completed | 2 | 48 | US, Europe | Cisplatin, Capecitabine, Telatinib | ACT Biotech, Inc | Gastric Cancer | 10/11 | 01/12 | | |
NCT00390416: Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma |
|
|
| Completed | 2 | 48 | US | Docetaxel, Cisplatin, Fluorouracil, Bevacizumab, Leucovorin | Memorial Sloan Kettering Cancer Center, Sanofi, Genentech, Inc. | Stomach Neoplasms, Esophageal Neoplasms | 01/12 | 01/12 | | |
| Completed | 2 | 59 | RoW | Docetaxel, Cisplatin, Fluorouracil | Sanofi | Stomach Neoplasms | 03/12 | 03/12 | | |
NCT00601705: Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach |
|
|
| Completed | 2 | 61 | US | cisplatin, epirubicin hydrochloride, fluorouracil, oxaliplatin, adjuvant therapy, neoadjuvant therapy | Case Comprehensive Cancer Center, National Cancer Institute (NCI) | Esophageal Cancer, Gastric Cancer | 03/12 | 01/15 | | |
NCT01286766: Neoadjuvant Combination Chemotherapy of DCS (Cisplatin + Docetaxel + S-1) and DCF (Docetaxel + Cisplatin + 5-FU) in Patients With Locally Advanced Gastric Adenocarcinoma |
|
|
| Completed | 2 | 6 | RoW | DCS (docetaxel with cisplatin with TS-1), Taxotere, CDDP, TS-1, DCF (docetaxel with cisplatin with 5-FU), 5-FU | Yonsei University | Gastric Cancer | 06/12 | 06/12 | | |
| Completed | 2 | 40 | Europe | Cetuximab, Cisplatin, S-1 | Merck KGaA, Darmstadt, Germany | Gastric Cancer | 08/12 | 05/13 | | |
NCT00632268: Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric Cancer |
|
|
| Completed | 2 | 40 | RoW | RAD001; Cisplatin; 5-FU; Leucovorin | National Taiwan University Hospital, National Cheng-Kung University Hospital, Taipei Veterans General Hospital, Taiwan | Metastatic Gastric Cancer | 09/12 | 12/12 | | |
| Completed | 2 | 50 | Europe | Docetaxel, Taxotere, cisplatin, Capecitabine, Xeloda, D1extra-resection | Jeroen Bosch Ziekenhuis, Eindhoven Cancer Registry | Gastric Cancer | 11/12 | 05/13 | | |
NCT01360086: Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal Junction |
|
|
| Completed | 2 | 65 | Europe | cetuximab, cisplatin, fluorouracil, leucovorin calcium, adjuvant therapy, neoadjuvant therapy, quality-of-life assessment, therapeutic conventional surgery | Federation Francophone de Cancerologie Digestive | Adenocarcinoma of the Gastroesophageal Junction, Gastric Cancer | 03/13 | 03/13 | | |
|
NCT01736410: A Phase 2 Study of Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer |
|
|
| Completed | 2 | 30 | RoW | Trastuzumab, TS ONE, Cisplatin | National Cancer Centre, Singapore | HER 2 Positive Advanced Gastric Cancer | 04/13 | 05/13 | | |
|
NCT01123473 / 2009-011580-36: Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer |
|
|
| Terminated | 2 | 29 | Europe | capecitabine, cisplatin, epirubicin hydrochloride, fluorouracil, lapatinib ditosylate | European Organisation for Research and Treatment of Cancer - EORTC | Adenocarcinoma of the Gastroesophageal Junction, Gastric Cancer | 08/13 | 09/14 | | |
|
NCT01444521: Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer |
|
|
| Completed | 2 | 50 | RoW | irinotecan and cisplatin, CAMPT | Chinese Academy of Medical Sciences | Gastric Cancer | 05/14 | 05/14 | | |
NCT00737438: Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma |
|
|
| Completed | 2 | 22 | US | epirubicin, cisplatin, capecitabine, bevacizumab, docetaxel and irinotecan, Patients who have a poor PET response to cycle 1 of ECX plus bevacizumab, (eg. < 35% FDG reduction on the week 3 PET scan compared with baseline), will be switched to salvage therapy of docetaxel and irinotecan (DI)., This treatment will be administered on week 1 and 2 of a 3, week cycle for 2 cycles. Patients will receive bevacizumab for the 1st cycle, of salvage docetaxel/irinotecan only. There is again a planned 10-12 week time, interval (eg. 70-84 days) between the last bevacizumab treatment and surgery. | Memorial Sloan Kettering Cancer Center, Genentech, Inc., Weill Medical College of Cornell University | Esophageal Cancer, Gastric Cancer | 02/15 | 02/15 | | |
|
NCT01830270: Preoperative Dose-dense Chemotherapy With Weekly Cisplatin, Epirubicin and Paclitaxel to Treat Patients With Locally Gastric Cancer |
|
|
| Terminated | 2 | 30 | Europe | Epirubicin, Cisplatin, Paclitaxel, gastric surgery | Centre Hospitalier Universitaire de Besancon | Stomach Neoplasms, Oesophageal Junction Cancer, Lower Oesophagus Cancer | 04/15 | 07/16 | | |
NCT01715233: Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer. |
|
|
| Completed | 2 | 27 | US | Docetaxel, Modified DCF, Leucovorin, Fluorouracil, FU, Cisplatin, Carboplatin | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Metastatic Esophageal Cancer, Gastroesophageal Cancer, Gastric Cancer | 06/15 | 04/17 | | |
NCT01283204: Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer |
|
|
| Completed | 2 | 180 | RoW | SP, TS-1® with Cisplatin, FL/Tax, Paclitaxel with Leucovorin with 5-FU, FL/Doc, Docetaxel with Leucovorin with 5-FU, FOLFOX, Oxaliplatin with Leucovorin with 5-FU | Yonsei University | Recurrent or Metastatic Gastric Cancer | 07/16 | 07/16 | | |
| Completed | 2 | 171 | Europe | Epirubicin, Cisplatin, Capecitabine, Panitumumab, Xeloda®, Epirubicin, Cisplatin, Capecitabine, Vectibix®, Xeloda® | AIO-Studien-gGmbH, Amgen, WiSP Wissenschaftlicher Service Pharma GmbH | Stomach Neoplasms, Gastroesophageal Junction Neoplasms | 08/16 | 08/17 | | |
| Completed | 1b/2 | 130 | US, Canada, Europe, RoW | Capecitabine, Xeloda, Epirubicin, AMG 102, Cisplatin, Placebo | Amgen | Esophagogastric Junction Adenocarcinoma, Gastric Cancer, Esophageal Cancer | 11/10 | 06/13 | | |
|
|
|
|
NCT00072787: Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer |
|
|
| Completed | 1/2 | 41 | US | S-1, cisplatin | Taiho Oncology, Inc. | Gastric Cancer | 03/06 | 05/06 | | |
NCT00320515: Study of Pemetrexed Plus Cisplatin in Advanced Gastric Cancer |
|
|
| Completed | 1/2 | 89 | RoW | pemetrexed, LY231514, Alimta, cisplatin | Eli Lilly and Company | Neoplasm, Gastric | 07/08 | 07/08 | | |
NCT01611506: Combination Chemotherapy, Cetuximab and Radiation for Patients With Localized Gastric Cancer |
|
|
| Terminated | 1/2 | 1 | Europe | Cetuximab, Capecitabine, Cisplatin | Dr Anna Dorothea Wagner | Gastric Cancer | 12/12 | 12/12 | | |
NCT01355302 / 2011-000774-58: E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer |
|
|
| Terminated | 1/2 | 7 | US, Europe, RoW | E7050, cisplatin, capecitabine | Eisai Inc., Quintiles, Inc. | Advanced or Metastatic Solid Tumors, Previously Untreated Gastric Cancer | 04/13 | 07/13 | | |
NCT00188266: Study of Adjuvant Radiochemotherapy for Gastric Cancer |
|
|
| Completed | 1/2 | 65 | Canada | cisplatinum combined with infusional fluorouracil (5 FU) | University Health Network, Toronto, Princess Margaret Hospital, Canada | Stomach Neoplasms | 12/13 | 08/17 | | |
XPID, NCT01525771: Safety Study of Combined Systemic and Intraperitoneal Chemotherapy to Treat Stomach Cancer |
|
|
| Completed | 1/2 | 37 | RoW | Docetaxel, XP with Intraperitoneal Docetaxel, Capecitabine, Cisplatin | Asan Medical Center | Stage IV Gastric Cancer With Metastasis | 12/14 | 12/14 | | |
| Terminated | 1/2 | 51 | Europe | Pazopanib, Pazopanib: 800mg once a day for up to 2 years from date of first dose | Hellenic Oncology Research Group | Gastric Cancer | 01/15 | 01/15 | | |
NCT01783951: Study of S-1 Plus DC-CIK for Patients With Advanced Gastric Cancer |
|
|
| Completed | 1/2 | 63 | RoW | DC-CIK, S-1, Cisplatin | Capital Medical University, Duke University, Geneplus-Beijing Co. Ltd. | Gastric Cancer | 02/18 | 06/18 | | |
